ArticleGenome research2025

Alternative splicing generates HER2 isoform diversity underlying antibody-drug conjugate resistance in breast cancer.

Gabriela D A Guardia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.